SCHEMBL8625916

SCHEMBL8625916

CC(N)C(Cc1ccc(Cl)cc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.51
SLC6A3 Q01959 7/20 0.51
PNMT P11086 1/20 0.51
SLC6A4 P31645 7/20 0.46
ADRB2 P07550 1/20 0.43
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39
CNR1 P21554 5/20 0.38
CNR2 P34972 4/20 0.38
KCNH2 Q12809 5/20 0.38
CYP3A4 P08684 5/20 0.38
CYP2D6 P10635 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8622251 0.91 PNMT (0.60) SLC6A2SLC6A3PNMTSLC6A4ADRB2
SCHEMBL4691720 0.87 SLC6A3 (0.62) SLC6A2SLC6A3PNMTSLC6A4ADRB2
SCHEMBL8620429 0.85 FDFT1 (0.47) SLC6A2SLC6A3PNMTSLC6A4CNR1
Hydrochloric Acid SCHEMBL3371509 0.85 SLC6A2 (0.60) SLC6A2SLC6A3SLC6A4ADRB2LMNA
SCHEMBL8619441 0.82 SLC6A2 (0.56) SLC6A2SLC6A3SLC6A4ADRB2CNR1
SCHEMBL8621289 0.82 SLC6A2 (0.56) SLC6A2SLC6A3SLC6A4ADRB2CNR1
SCHEMBL200500 0.81 SLC6A2 (0.56) SLC6A2SLC6A3PNMTSLC6A4CNR1
SCHEMBL8626123 0.81 SLC6A3 (0.55) SLC6A2SLC6A3SLC6A4ADRB2CNR1
SCHEMBL8622953 0.81 SLC6A3 (0.55) SLC6A2SLC6A3SLC6A4ADRB2CNR1
SCHEMBL8625124 0.81 HTR2A (0.50) SLC6A2SLC6A3SLC6A4CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5777150-A Substituted amic acid derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-07-07 US disclosed
US-5616803-A EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-04-01 US disclosed
US-5606101-A INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-02-25 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed